Effect of desipramine on gene expression in the mouse frontal cortex - Microarray study

被引：3

作者：

Solich, Joanna ^{[1
]}

Kolasa, Magdalena ^{[1
]}

Kusmider, Maciej ^{[1
]}

Faron-Gorecka, Agata ^{[1
]}

Pabian, Paulina ^{[1
]}

Szafran, Kinga ^{[1
]}

Zurawek, Dariusz ^{[1
]}

Dziedzicka-Wasylewska, Marta ^{[1
]}

机构：

[1] Polish Acad Sci, Inst Pharmacol, Dept Pharmacol, Krakow, Poland

来源：

PHARMACOLOGICAL REPORTS | 2015年 / 67卷 / 02期

关键词：

Desipramine; Gene expression; Microarray; Mice; MESSENGER-RNA EXPRESSION; CELL-ADHESION MOLECULES; SEROTONIN TRANSPORTER; ANTIDEPRESSANT DRUGS; CANDIDATE GENES; CHRONIC STRESS; MODEL; PHARMACOGENOMICS; LYMPHOCYTES; INVOLVEMENT;

D O I：

10.1016/j.pharep.2014.09.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Background: These studies aimed to identify the genes differentially expressed in the frontal cortex of mice treated repeatedly with either saline or desiprarnine (DMI). Methods: Differences in gene expression in the mouse frontal cortex were studied using a whole-genome microarray approach. Results: The analyses revealed a group of 88 transcripts (18 genes) that were differentially expressed between the mice treated with saline and those treated with DMI. These genes include Spnb2, Mef2c, Ncam1, Hsp90ab1, Kif1b, Ddx6 and Gsk3b, which were connected in the gene relationship network. Conclusions: It appears that one week of DMI administration measurably altered the expression of a small number of genes, including genes connected with neuroplasticity and cytoskeletal changes, the regulation of calcium levels in the cell or translation processes. (C) 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

引用

页码：345 / 348

页数：4

共 38 条

[11] Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level [J].

Gaska, Magdalena ;

Kusmider, Maciej ;

Solich, Joanna ;

Faron-Gorecka, Agata ;

Krawczyk, Malgorzata J. ;

Kulakowski, Krzysztof ;

Dziedzicka-Wasylewska, Marta .

PSYCHOPHARMACOLOGY, 2012, 223 (03) :281-297

[12] Using a pharmacogenomic algorithm to guide the treatment of depression [J].

Hall-Flavin, D. K. ;

Winner, J. G. ;

Allen, J. D. ;

Jordan, J. J. ;

Nesheim, R. S. ;

Snyder, K. A. ;

Drews, M. S. ;

Eisterhold, L. L. ;

Biernacka, J. M. ;

Mrazek, D. A. .

TRANSLATIONAL PSYCHIATRY, 2012, 2 :e172-e172

[13] The corticosteroid receptor hypothesis of depression [J].

Holsboer, F .

NEUROPSYCHOPHARMACOLOGY, 2000, 23 (05) :477-501

[14] Pharmacogenomics of antidepressant drugs [J].

Horstmann, Sonja ;

Binder, Elisabeth B. .

PHARMACOLOGY & THERAPEUTICS, 2009, 124 (01) :57-73

[15] Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine [J].

Iga, J ;

Ueno, S ;

Yamauchi, K ;

Motoki, I ;

Tayoshi, S ;

Ohta, K ;

Song, HW ;

Morita, K ;

Rokutan, K ;

Ohmori, T .

NEUROSCIENCE LETTERS, 2005, 389 (01) :12-16

[16] Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches Masashi Ikeda [J].

Ikeda, Masashi ;

Tomita, Yasuyuki ;

Mouri, Akihiro ;

Koga, Minori ;

Okochi, Tomo ;

Yoshimura, Reiji ;

Yamanouchi, Yoshio ;

Kinoshita, Yoko ;

Hashimoto, Ryota ;

Williams, Hywel J. ;

Takeda, Masatoshi ;

Nakamura, Jun ;

Nabeshima, Toshitaka ;

Owen, Michael J. ;

O'Donovan, Michael C. ;

Honda, Hiroyuki ;

Arinami, Tadao ;

Ozaki, Norio ;

Iwata, Nakao .

BIOLOGICAL PSYCHIATRY, 2010, 67 (03) :263-269

[17] Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder [J].

Kato, M. ;

Serretti, A. .

MOLECULAR PSYCHIATRY, 2010, 15 (05) :473-500

[18] Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice [J].

Lucki, I ;

Dalvi, A ;

Mayorga, AJ .

PSYCHOPHARMACOLOGY, 2001, 155 (03) :315-322

[19] Reduced glucocorticoid receptor α expression in mood disorder patients and first-degree relatives [J].

Matsubara, T ;

Funato, H ;

Kobayashi, A ;

Nobumoto, M ;

Watanabe, Y .

BIOLOGICAL PSYCHIATRY, 2006, 59 (08) :689-695

[20] Gene expression: Biomarker of antidepressant therapy? [J].

Menke, Andreas .

INTERNATIONAL REVIEW OF PSYCHIATRY, 2013, 25 (05) :579-591

← 1 2 3 4 →